ClinicalTrials.Veeva

Menu

Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans (SEINE)

C

Centre Hospitalier Intercommunal Creteil

Status

Terminated

Conditions

Sequela
Meningitis, Meningococcal

Treatments

Other: sequela evaluation

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

While the initial evolution of meningococcal meningitis (MM) is well described, there are few data on the long-term evolution, beyond 1 year.

The objective of this research is to evaluate the sequelae of MM beyond 1 year in patients with a history of MM followed in Paris area, France. Most children with MM in France have been included in the MM register and are still being followed. Parents will be offered a detailed clinical evaluation of their child including: a clinical and neurological examination, a cognitive performance assessment, an auditory, speech and visual assessment and an evaluation of the child's progress at school.

Enrollment

43 patients

Sex

All

Ages

Under 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants and children from 0 to 17 years old
  • Having had meningitis or meningococcal purpura fulminans between 2010 and 2021
  • Delay ≥ 1 year between the date of diagnosis of meningitis or purpura meningococcal fulminans and the date of inclusion in the study (signature of the informed consent)
  • The holders of parental authority have read and understood the information letter and their express consent has been obtained
  • Patient affiliated to a social security system (Social Security or Universal Medical Coverage)

Exclusion criteria

  • refusal to participate

Trial contacts and locations

9

Loading...

Central trial contact

Camille JUNG; Robert COHEN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems